Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
BPC-157 administration through subcutaneous injection represents the most practical approach for self-administration, offering good absorption with minimal skill requirements compared to intramuscular injection
Benefits (Research Focus) Multi-pathway research studied for paired investigation across four distinct peptide signaling pathways in a single research blend Tissue repair pathways investigated via BPC-157 and TB-500 components for angiogenesis and fibroblast migration endpoints Copper-peptide research explored via GHK-Cu for fibroblast activation, collagen synthesis, and dermal matrix remodeling Anti-inflammatory signaling examined via KPV (-MSHderived tripeptide) for NF-B pathway and inflammatory cytokine modulation Comparative pharmacology researched for paired vs single-compound endpoint differences across tissue repair, dermal, and inflammation models What Researchers Look At Fibroblast activation, collagen Type I/III synthesis, and dermal matrix protein expression Angiogenesis markers (VEGF, integrins) and endothelial cell migration assays NF-B pathway activity and inflammatory cytokine (TNF-, IL-6) modulation Wound closure rates and dermal repair endpoints in preclinical models Multi-component blend pharmacology versus single-peptide administration Quick Specs Form: Lyophilized white-to-blue powder (color from GHK-Cu copper complex) BPC-157: [add mg per COA] TB-500: [add mg per COA] GHK-Cu: [add mg per COA] KPV: [add mg per COA] Total Peptide Content: [80 mg or 100 mg per vial confirm against COA] Quantity: 1 vial Appearance: Pale blue to white lyophilizate Reconstitution: Bacteriostatic or sterile water (added by the end researcher) Purity: 99% by HPLC (per component) Identity: MS-verified (per COA) Storage: Protect from light Identity Basics Compound 1: BPC-157 (Body Protection Compound-157) Class: Synthetic pentadecapeptide
In different preclinical research models, Tesamorelin has been studied as a GHRH receptor agonist on pituitary somatotroph cells
Now Offering Tirzepatide and Semaglutide Injections Tirzepatide and Semaglutide are weekly weight loss injections that mimic a hormone the body releases after a meal called GLP-1, signaling fullness and lowering appetite
Compared with other teas, green tea contains more catechins
Other antioxidants such as vitamin C, E, and lipoic acid need to have enough S-acetyl-L-glutathione to neutralize and free radicals
